thyroxine has been researched along with Basal Ganglia Diseases in 2 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, 93 chronic inpatients with schizophrenia were comprehensively investigated in order to examine the association of psychiatric and extrapyramidal symptoms with prolactin, thyroid hormones (free triiodothyronine (T₃), free thyroxine (T₄), thyroid stimulating hormone), cortisol and BDNF." | 7.78 | Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia. ( Hoaki, N; Hoaki, T; Ichioka, S; Matsushita, T; Terao, T, 2012) |
| "In this study, 93 chronic inpatients with schizophrenia were comprehensively investigated in order to examine the association of psychiatric and extrapyramidal symptoms with prolactin, thyroid hormones (free triiodothyronine (T₃), free thyroxine (T₄), thyroid stimulating hormone), cortisol and BDNF." | 3.78 | Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia. ( Hoaki, N; Hoaki, T; Ichioka, S; Matsushita, T; Terao, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichioka, S | 1 |
| Terao, T | 1 |
| Hoaki, N | 1 |
| Matsushita, T | 1 |
| Hoaki, T | 1 |
| Arii, J | 1 |
| Tanabe, Y | 1 |
| Makino, M | 1 |
| Sato, H | 1 |
| Kohno, Y | 1 |
2 other studies available for thyroxine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Brain-Derived Neurotro | 2012 |
Children with irreversible brain damage associated with hypothyroidism and multiple intracranial calcifications.
Topics: Basal Ganglia Diseases; Calcinosis; Cerebral Palsy; Child, Preschool; Female; Growth Disorders; Huma | 2002 |